Location History:
- Wellesley, MA (US) (1999 - 2001)
- Boston, MA (US) (1998 - 2002)
Company Filing History:
10 out of 850 
2 out of 36 Years Active: 1998-2002
Title: **Carlos J Gimeno: Innovator in Therapeutics and Diagnostics**
Introduction
Carlos J Gimeno is a prominent inventor based in Wellesley, MA, with a remarkable portfolio of 12 patents. His contributions to the field of biomedical research focus on therapeutic and diagnostic innovations, particularly related to G-protein coupled receptors and polypeptides.
Latest Patents
Among Carlos J Gimeno's latest patents is a significant discovery related to RP compositions and therapeutic and diagnostic uses. This invention revolves around novel genes that encode rp polypeptides, which have potential applications in therapeutics, diagnostics, and screening assays. Another notable patent involves an assay designed to identify agents that alter G-protein coupled receptor activity. This invention features a transformed yeast cell that includes a heterologous nucleic acid sequence coding for a G-protein coupled receptor and another sequence for the yeast Gα subunit protein Gpa2. The innovation allows for in vitro high throughput assays that can screen for agonists and antagonists of ligand activity, proving vital for advancing drug discovery.
Career Highlights
Throughout his career, Carlos J Gimeno has been associated with leading companies in the pharmaceutical sector, including Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. His work has substantially contributed to advancements in therapeutic solutions and drug development.
Collaborations
Carlos has collaborated with notable professionals in his field, including Patrick R Errada and Dean A Falb. These partnerships have played a crucial role in shaping his inventive pursuits and enhancing the impact of his research on public health.
Conclusion
Carlos J Gimeno stands out as an influential figure in the realms of therapeutics and diagnostics. With an impressive number of patents and a strong collaborative network, he continues to push the boundaries of innovation, aiming to improve medical outcomes through his pioneering work. His contributions highlight the importance of research and development in overcoming health challenges and advancing medical science.